SCHEMBL5289524

SCHEMBL5289524

COc1cc(CC(=O)Nc2ccc3ncn(C(CC(=O)O)c4ccccc4)c3c2)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.44
ITGA4 P13612 1/20 0.44
BCHE P06276 4/20 0.43
ACHE P22303 4/20 0.43
KDR P35968 1/20 0.42
ALDH1A1 P00352 3/20 0.42
GAA P10253 2/20 0.42
TSHR P16473 2/20 0.42
NFKB1 P19838 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
HSD17B10 Q99714 2/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MEN1 O00255 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5305927 0.93 BCHE (0.51) ITGB1ITGA4BCHEACHEKDR
SCHEMBL5307759 0.93 KDR (0.44) ITGB1ITGA4BCHEACHEKDR
SCHEMBL5291502 0.90 BCHE (0.46) ITGB1ITGA4BCHEACHELMNA
SCHEMBL2292763 0.88 MAPT (0.50) ALDH1A1LMNAMAPTHSD17B10KDM4E
SCHEMBL5303427 0.87 BCHE (0.51) ITGB1ITGA4BCHEACHEKDR
SCHEMBL2294905 0.86 USP2 (0.51) ALDH1A1LMNAMAPTPOLBMEN1
SCHEMBL2295247 0.86 LMNA (0.50) ALDH1A1TSHRLMNAMAPTKDM4E
SCHEMBL2294482 0.86 NAMPT (0.48) ITGB1ITGA4ALDH1A1GAALMNA
SCHEMBL5289381 0.85 ITGB1 (0.44) ITGB1ITGA4KDRMAPTKDM4E
SCHEMBL2298594 0.84 KMT2A (0.46) ITGB1ITGA4ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed